These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 9645808)

  • 41. Prolonged murine cardiac allograft acceptance: characteristics of persistent active alloimmunity after treatment with gallium nitrate versus anti-CD4 monoclonal antibody.
    Orosz CG; Wakely E; Sedmak DD; Bergese SD; VanBuskirk AM
    Transplantation; 1997 Apr; 63(8):1109-17. PubMed ID: 9133472
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Allograft rejection requires STAT5a/b-regulated antiapoptotic activity in T cells but not B cells.
    Zhang Y; Kirken RA; Furian L; Janczewska S; Qu X; Hancock WW; Wang M; Tejpal N; Kerman R; Kahan BD; Stepkowski SM
    J Immunol; 2006 Jan; 176(1):128-37. PubMed ID: 16365403
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Donor deficiency of decay-accelerating factor accelerates murine T cell-mediated cardiac allograft rejection.
    Pavlov V; Raedler H; Yuan S; Leisman S; Kwan WH; Lalli PN; Medof ME; Heeger PS
    J Immunol; 2008 Oct; 181(7):4580-9. PubMed ID: 18802060
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CCR4-deficient mice show prolonged graft survival in a chronic cardiac transplant rejection model.
    Hüser N; Tertilt C; Gerauer K; Maier S; Traeger T; Assfalg V; Reiter R; Heidecke CD; Pfeffer K
    Eur J Immunol; 2005 Jan; 35(1):128-38. PubMed ID: 15593118
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Donor-specific antibodies in allograft rejection: clinical and experimental data.
    Rifle G; Mousson C; Martin L; Guignier F; Hajji K
    Transplantation; 2005 Feb; 79(3 Suppl):S14-8. PubMed ID: 15699738
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term control of alloreactive B cell responses by the suppression of T cell help.
    Li Y; Ma L; Yin D; Shen J; Chong AS
    J Immunol; 2008 May; 180(9):6077-84. PubMed ID: 18424729
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Absence of Activation-induced Cytidine Deaminase, a Regulator of Class Switch Recombination and Hypermutation in B Cells, Suppresses Aorta Allograft Vasculopathy in Mice.
    Nakanishi T; Xu X; Wynn C; Yamada T; Pan F; Erickson L; Teo H; Nakagawa T; Masunaga T; Abe J; Akamatsu M; Tamura K; Jiang H
    Transplantation; 2015 Aug; 99(8):1598-605. PubMed ID: 25769064
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modification of humoral responses by the combination of leflunomide and cyclosporine in Lewis rats transplanted with hamster hearts.
    Chong AS; Ma LL; Shen J; Blinder L; Yin DP; Williams JW
    Transplantation; 1997 Dec; 64(12):1650-7. PubMed ID: 9422397
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Abrogation of antibody-mediated allograft rejection by regulatory CD4 T cells with indirect allospecificity.
    Callaghan CJ; Rouhani FJ; Negus MC; Curry AJ; Bolton EM; Bradley JA; Pettigrew GJ
    J Immunol; 2007 Feb; 178(4):2221-8. PubMed ID: 17277127
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Donor-specific transfusion does not mitigate but accelerates rejection of intravenously transplanted lymphocytes.
    Jaskłowska-Englisz M; Podgórska D; Adamczyk G; Olszewski WL
    Arch Immunol Ther Exp (Warsz); 1993; 41(5-6):365-71. PubMed ID: 8010878
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of CXCR3 and CCR5 in allograft rejection.
    Schnickel GT; Hsieh GR; Garcia C; Shefizadeh A; Fishbein MC; Ardehali A
    Transplant Proc; 2006 Dec; 38(10):3221-4. PubMed ID: 17175228
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CD4 T cell-mediated rejection of cardiac allografts in B cell-deficient mice.
    Nozaki T; Rosenblum JM; Ishii D; Tanabe K; Fairchild RL
    J Immunol; 2008 Oct; 181(8):5257-63. PubMed ID: 18832680
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Induction of donor-specific tolerance to cardiac but not skin or renal allografts by intrathymic injection of splenocyte alloantigen.
    Nakafusa Y; Goss JA; Mohanakumar T; Flye MW
    Transplantation; 1993 Apr; 55(4):877-82. PubMed ID: 8475563
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Renal allograft rejection, lymphocyte infiltration, and de novo donor-specific antibodies in a novel model of non-adherence to immunosuppressive therapy.
    Kühne L; Jung B; Poth H; Schuster A; Wurm S; Ruemmele P; Banas B; Bergler T
    BMC Immunol; 2017 Dec; 18(1):52. PubMed ID: 29258420
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prolongation of cardiac allograft survival by rapamycin and the invariant natural killer T cell glycolipid agonist OCH.
    Haeryfar SM; Lan Z; Leon-Ponte M; Duffy KR; Ge W; Liu W; Mele T; Garcia B; Wang H
    Transplantation; 2008 Aug; 86(3):460-8. PubMed ID: 18698251
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prolonged heart allograft survival resulted from donor-specific T-cell sequestering and removal by selective splenectomy in mice.
    Zhu XH; Chen S; Chen ZK
    Transplant Proc; 2004 Oct; 36(8):2448-9. PubMed ID: 15561276
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Permanent survival of fully MHC-mismatched islet allografts by targeting a single chemokine receptor pathway.
    Wang L; Han R; Lee I; Hancock AS; Xiong G; Gunn MD; Hancock WW
    J Immunol; 2005 Nov; 175(10):6311-8. PubMed ID: 16272282
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Induction of regulatory cells and control of cellular but not vascular rejection by costimulation blockade in hamster-to-rat heart xenotransplantation.
    Séveno C; Coulon F; Haspot F; Mérieau E; Renaudin K; Martinet B; Vanhove B
    Xenotransplantation; 2007 Jan; 14(1):25-33. PubMed ID: 17214702
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [TBL] [Abstract][Full Text] [Related]  

  • 60. IL-3 Triggers Chronic Rejection of Cardiac Allografts by Activation of Infiltrating Basophils.
    Balam S; Schiechl-Brachner G; Buchtler S; Halbritter D; Schmidbauer K; Talke Y; Neumayer S; Salewski JN; Winter F; Karasuyama H; Yamanishi Y; Renner K; Geissler EK; Mack M
    J Immunol; 2019 Jun; 202(12):3514-3523. PubMed ID: 31068389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.